TRVI Key Financial Ratios - Trevi Therapeutics, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	37.28	—	-15.46%	-15.90%
2026-03-31	24.75	—	-25.40%	-26.50%
2025-12-31	19.66	—	-22.10%	-23.33%
2025-09-30	21.93	—	-23.00%	-24.16%
2025-06-30	22.42	—	-22.70%	-23.83%
2025-03-31	15.38	—	-44.25%	-47.61%
2024-12-31	10.41	—	-43.20%	-48.08%
2024-09-30	7.38	—	-64.31%	-75.15%
2024-06-30	10.68	—	-52.53%	-58.59%
2024-03-31	14.55	—	-42.73%	-46.40%
2023-12-31	15.03	—	-32.51%	-35.21%
2023-09-30	18.16	—	-27.89%	-29.85%
2023-06-30	21.06	—	-27.05%	-28.73%
2023-03-31	8.65	—	-24.29%	-27.74%
2022-12-31	9.15	—	-23.70%	-27.13%
2022-09-30	8.7	—	-25.06%	-29.27%
2022-06-30	5.18	—	-38.27%	-51.48%
2022-03-31	2.32	—	-108.27%	-314.42%
2021-12-31	2.98	—	-88.21%	-198.77%
2021-09-30	3.1	—	-110.59%	-307.06%
2021-06-30	4.09	—	-89.57%	-197.71%
2021-03-31	7.9	—	-76.19%	-137.88%
2020-12-31	8.33	—	-69.50%	-120.07%
2020-09-30	9.05	—	-53.28%	-83.59%
2020-06-30	6.85	—	-63.30%	-74.33%
2020-03-31	7.47	—	-54.80%	-63.50%
2019-12-31	11.45	—	-43.42%	-47.76%
2019-09-30	13.03	—	-38.62%	-42.00%
2019-06-30	10.5	—	-31.66%	-35.13%
2019-03-31	4.03	—	-123.92%	18.44%
2018-12-31	3.3	—	-195.18%	18.76%

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	19.66	—	-22.10%	-23.33%
2024-12-31	10.41	—	-43.20%	-48.08%
2023-12-31	15.03	—	-32.51%	-35.21%
2022-12-31	9.15	—	-23.70%	-27.13%
2021-12-31	2.98	—	-88.21%	-198.77%
2020-12-31	8.33	—	-69.50%	-120.07%
2019-12-31	11.45	—	-43.42%	-47.76%
2018-12-31	3.3	—	-195.18%	18.76%